Joe Tran
12Patents
5h-index
43Co-inventors
66Inventor score
Filing activity: Sep 15, 2000 → Sep 2, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6682938B1 | Glucose sensing molecules having selected fluorescent properties | Human Necessities | 203 | Expired |
| US6673625B2 | Saccharide sensing molecules having enhanced fluorescent properties | Emerging Cross-Sectional Technologies | 169 | Expired |
| US8575177B2 | Pyrazolopyrimidines and related heterocycles as CK2 inhibitors | Human Necessities | 8 | Active |
| US11414439B2 | Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator | Human Necessities | 6 | Active |
| US9303033B2 | Pyrazolopyrimidines and related heterocycles as CK2 inhibitors | Human Necessities | 6 | Active |
| US8367681B2 | Pyrazolopyrimidines and related heterocycles as kinase inhibitors | Human Necessities | 3 | Active |
| US11434247B1 | Substituted furanopyrimidine compounds as PDE1 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US8293729B2 | Compounds, pharmaceutical composition and methods relating thereto | Chemistry; Metallurgy | 1 | Active |
| US11365191B2 | Substituted cyclohexyl compounds as NOP inhibiiors | Chemistry; Metallurgy | 1 | Active |
| US11945808B2 | Substituted cyclohexyl compounds as NOP inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12006325B2 | Substituted furanopyrimidine compounds as PDE1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8481731B2 | Compounds, pharmaceutical composition and methods relating thereto | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.